Related Experiment Videos
Inherited forms of renal cell carcinoma
M Kiuru1, M Kujala, K Aittomäki
1Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
Summary
Up to 2% of renal cell cancer (RCC) cases have a hereditary basis. Identifying genetic defects aids early diagnosis and surveillance, improving outcomes for hereditary kidney cancer patients.
Area of Science:
- Oncology
- Genetics
- Medical Research
Background:
- Hereditary renal cell cancer (RCC) accounts for up to 2% of cases.
- Specific genetic syndromes like von Hippel-Lindau (VHL) disease, hereditary leiomyomatosis and renal cell cancer (HLRCC), and hereditary papillary renal cell carcinoma (HPRC) predispose individuals to RCC.
- Understanding the genetic basis of these syndromes is crucial for unraveling RCC's molecular pathogenesis.
Purpose of the Study:
- To provide guidance for the identification and management of patients with hereditary kidney cancer.
- To highlight the importance of genetic testing for early diagnosis and surveillance strategies.
- To emphasize how tailored management improves disease outcomes in hereditary cancer susceptibility.
Main Methods:
- This review synthesizes current knowledge on hereditary RCC syndromes.
- It focuses on clinical, histopathological, and genetic features of known hereditary RCC types.
- The review discusses the implications of genetic testing and screening for patient management.
Main Results:
- Identification of specific gene mutations (e.g., VHL gene) clarifies the molecular pathways in RCC.
- Genetic testing allows for the diagnosis of at-risk individuals.
- Surveillance protocols can lead to the detection of early-stage, presymptomatic tumors.
Conclusions:
- Identifying individuals with inherited cancer susceptibility is vital for implementing specialized management plans.
- Early diagnosis through genetic testing and proactive screening significantly improves prognosis.
- Effective management strategies for hereditary renal cancer patients enhance disease outcomes.